Ayala Pharmaceuticals Inc (ADXS)

[attilathehunt]

Perhaps. It kind of read to me like conditional approval, where you get to go to market but have to continue validating with trial results. It doesn't say "at the time of application" it says "at the time of marketing authorization".

You may be right! What I was thinking, they submit data at the time of application and since the application can take six months they need to submit the (latest) data again at the authorization meeting (if there is a meeting) to ensure the data is consistent to what was previously provided. In any event, it seems like we are further along then most thought. Perhaps the reason for today's move with above average volume.